| Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) (NCT02512510) | Mylan Inc. | 2015-09-01 |
| Phase IV O2 Consumption Study in COPD Patients. (NCT02533505) | AstraZeneca | 2015-08-25 |
| High-flow Nasal Cannula Therapy for Stable Chronic Obstructive Pulmonary Disease (COPD) (NCT02545855) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2015-08-17 |
| Walk On! Physical Activity Coaching (NCT02478359) | Kaiser Permanente | 2015-06-01 |
| Exacerbation Self-management in COPD: The ACCESS Study (NCT02553096) | Radboud University Medical Center | 2015-06-01 |
| TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects (NCT02772159) | Mylan Inc. | 2015-06-01 |
| Juno Perth Clinical Trial (NCT02317042) | ResMed | 2015-05-29 |
| 2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients (NCT02579850) | Chiesi Farmaceutici S.p.A. | 2015-05-29 |
| Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients (NCT02442206) | Novartis Pharmaceuticals | 2015-05-18 |
| Altitude Related Illness In Patients With Respiratory Disease (NCT02450968) | University of Zurich | 2015-05-01 |
| Effect of Dexamethasone on Sleep Related Breathing Disturbances in Patients With COPD at Altitude (NCT02450994) | University of Zurich | 2015-05-01 |
| A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251 (NCT02449018) | Novartis Pharmaceuticals | 2015-04-30 |
| Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (NCT02098369) | University of Illinois at Chicago | 2015-04-01 |
| Cell Therapy in Advanced Chronic Obstructive Pulmonary Disease Patients (NCT02412332) | UPECLIN HC FM Botucatu Unesp | 2015-04-01 |
| Identifying REsponders and Exploring Mechanisms of ACTION of the Endobronchial Coil Treatment for Emphysema (NCT02179125) | University Medical Center Groningen | 2015-03-01 |
| Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017 (NCT02315131) | Teva Branded Pharmaceutical Products R&D, Inc. | 2015-03-01 |
| Examine the Impact of Early Education on COPD Management (NCT02398643) | University of Alberta | 2015-03-01 |
| Examining Pulmonary Rehabilitation on Discharged COPD Patients (NCT02426437) | University of Alberta | 2015-02-01 |
| Effects of Inspiratory and Expiratory Pressure Training Methods in Patients With Chronic Obstructive Pulmonary Disease (NCT02326181) | Zhujiang Hospital | 2015-01-01 |
| Doxycycline for COPD in HIV-Infected Patients (NCT01744093) | Weill Medical College of Cornell University | 2014-12-08 |
| Effects of Combined Cycle Training and Inspiratory Muscle Training in Patients With COPD (NCT02200549) | Zhujiang Hospital | 2014-12-01 |
| Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD (NCT02296047) | Zhujiang Hospital | 2014-12-01 |
| Aides in Respiration Health Coaching for COPD (NCT02234284) | University of California, San Francisco | 2014-11-12 |
| A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects (NCT02275481) | Sumitomo Pharma America, Inc. | 2014-11-01 |
| Effects of CPAP Level on Respiratory Mechanics and Central Drive in Patients With COPD (NCT02285400) | Zhujiang Hospital | 2014-11-01 |
| A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy (NCT02238483) | AstraZeneca | 2014-10-28 |
| The SENSOR Study: A Mixed-methods Study of SElf-management Checks to Predict exacerbatioNs of Pseudomonas Aeruginosa in Patients With Long-term reSpiratORy Conditions (NCT02458807) | Portsmouth Hospitals NHS Trust | 2014-08-18 |
| Targeted Lung Denervation for Patients With Moderate to Severe COPD (NCT02058459) | Nuvaira, Inc. | 2014-08-04 |
| Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block (NCT02466503) | Intech Biopharm Ltd. | 2014-08-01 |
| Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients (NCT02305940) | Imperial College London | 2014-07-01 |
| Effects of Nutritional Supplementation in Malnourished Patients in Stable COPD (NCT02197871) | Zhujiang Hospital | 2014-07-01 |
| Seasonal Trends in Pneumococcal Carriage in COPD Patients (NCT02535546) | Beaumont Hospital | 2014-07-01 |
| Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study (NCT01853787) | University of Milan | 2014-07-01 |
| Comparison of Supervised Ground Walk Training and Treadmill Walk Training in COPD Patients (NCT02218918) | PSG Hospitals | 2014-07-01 |
| Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and Sleep (NCT02150590) | University of Zurich | 2014-06-01 |
| Targeted Retreatment of COPD Exacerbations (NCT02300220) | Imperial College London | 2014-05-05 |
| Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise Performance (NCT02143609) | University of Zurich | 2014-05-01 |
| Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD (NCT02165826) | AstraZeneca | 2014-05-01 |
| The Effect of Two Weeks of Voluntary Reduced Physical Activity in Chronic Obstructive Pulmonary Disease (COPD) (NCT02221804) | Royal Brompton & Harefield NHS Foundation Trust | 2014-05-01 |
| Efficacy and Safety Study of Two Dose Levels of AZD2115 in Subjects With Moderate to Severe COPD (NCT02109406) | Pearl Therapeutics, Inc. | 2014-05-01 |
| A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (NCT02153489) | AstraZeneca | 2014-04-01 |
| Home-monitoring and Adherence of Patients With COPD to Long-term Rehabilitation (NCT02122614) | Aveiro University | 2014-04-01 |
| Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD (NCT01917331) | Chiesi Farmaceutici S.p.A. | 2014-03-21 |
| Chen-style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease (NCT02370654) | Laval University | 2014-03-01 |
| Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients With COPD (NCT02078622) | StratiHealth | 2014-03-01 |
| Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health (NCT02236858) | Johns Hopkins University | 2014-03-01 |
| Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary Disease (NCT02042976) | University of Aarhus | 2014-02-01 |
| Physical Activity Versus Pulmonary Rehabilitation in COPD (NCT02161393) | University of Ulster | 2014-02-01 |
| A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment. (NCT02040597) | Chiesi Farmaceutici S.p.A. | 2014-01-01 |
| Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients (NCT02093195) | Air Force Military Medical University, China | 2013-12-01 |
| Image-Based Structural and Functional Phenotyping of the COSYCONET Cohort Using MRI and CT (NCT02629432) | University Hospital Heidelberg | 2013-12-01 |
| Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069 (NCT01962935) | AstraZeneca | 2013-11-01 |
| Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3) (NCT01970878) | Pearl Therapeutics, Inc. | 2013-11-01 |
| Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease (NCT01862536) | VA Office of Research and Development | 2013-10-01 |
| Examining Vascular Outcomes in COPD Inpatients (AIM 1) Examining Early Rehabilitation on Discharged COPD Patients (AIM 2) (NCT01949727) | University of Alberta | 2013-10-01 |
| Clinical Trials for Elderly Patients With Multiple Disease (NCT01960907) | Restech Srl | 2013-10-01 |
| Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients (NCT01970618) | Respivert Ltd | 2013-10-01 |
| Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability (NCT01615484) | University of North Carolina, Chapel Hill | 2013-09-01 |
| Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01908140) | AstraZeneca | 2013-09-01 |
| Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD (NCT02059434) | AstraZeneca | 2013-09-01 |
| Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema (NCT01908933) | Aeris Therapeutics | 2013-09-01 |
| A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management (NCT01893476) | Medical University of Lodz | 2013-09-01 |
| A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients (NCT01921712) | Pulmatrix Inc. | 2013-07-01 |
| Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD (NCT01915784) | Almirall, S.A. | 2013-07-01 |
| Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2) (NCT01854658) | Pearl Therapeutics, Inc. | 2013-07-01 |
| QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations) (NCT01782326) | Novartis Pharmaceuticals | 2013-07-01 |
| Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD (NCT01892488) | Hannover Medical School | 2013-06-07 |
| Brain During Effort : Effects of Hypoxia With Respiratory Patients (NCT02854280) | University Hospital, Grenoble | 2013-06-01 |
| Respiratory Muscle Function in COPD Exacerbations (NCT01869387) | Parc de Salut Mar | 2013-06-01 |
| Expanding Paramedicine in the Community (NCT02034045) | Unity Health Toronto | 2013-06-01 |
| Evaluation of the Efficacy and Safety of MV130 in Chronic Obstructive Pulmonary Disease (COPD) (NCT01842360) | Inmunotek S.L. | 2013-05-06 |
| Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI) (NCT01857323) | Teva Branded Pharmaceutical Products R&D, Inc. | 2013-05-01 |
| Patients With Chronic Obstructive Pulmonary Disease At Altitude (NCT01875133) | University of Zurich | 2013-05-01 |
| Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients (NCT01727024) | Novartis Pharmaceuticals | 2013-04-01 |
| Soins intégrés BPCO (Broncho-pneumopathie Chronique Obstructive) en Valais - Mieux Vivre Avec ma BPCO (COPD Integrated Care Program Valais - Living Well With COPD) (NCT02001922) | Centre Hospitalier du Centre du Valais | 2013-03-01 |
| Validation of Structured Light Plethysmography - Health and Disease (NCT02626468) | Pneumacare Ltd | 2013-03-01 |
| Developing a COPD Case Finding Methodology for Primary Care (NCT01880177) | University of Michigan | 2013-02-01 |
| A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects (NCT01754844) | AstraZeneca | 2013-01-01 |
| A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation (NCT01712516) | Novartis Pharmaceuticals | 2012-12-01 |
| Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control (NCT01715311) | Novartis Pharmaceuticals | 2012-11-01 |
| A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation. (NCT01727141) | Novartis Pharmaceuticals | 2012-11-01 |
| Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide. (NCT01699685) | Novartis Pharmaceuticals | 2012-11-01 |
| A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation (NCT01682863) | Novartis Pharmaceuticals | 2012-10-01 |
| Correlation Between Patient Perception and Findings on Clinical Examination in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01703416) | AstraZeneca | 2012-10-01 |
| Long Term Safety Study of NVA237 vs QAB149 in COPD Patients (NCT01697696) | Novartis Pharmaceuticals | 2012-10-01 |
| Prognosis and Treatment of COPD in Primary Care-use of Biomarkers (NCT01698151) | University of Southern Denmark | 2012-10-01 |
| Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation (NCT01610037) | Novartis Pharmaceuticals | 2012-10-01 |
| Evaluation of the IPS System for TLD Therapy in Patients With COPD (NCT01716598) | Nuvaira, Inc. | 2012-10-01 |
| Microbiology & Immunology of the Chronically-inflamed Airway (NCT01701869) | University Hospital Southampton NHS Foundation Trust | 2012-09-01 |
| Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies (NCT01776398) | Weill Medical College of Cornell University | 2012-08-29 |
| Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial (NCT01998724) | Beth Israel Deaconess Medical Center | 2012-08-01 |
| Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers (NCT01690949) | Pulmatrix Inc. | 2012-08-01 |
| Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD) (NCT01646424) | AstraZeneca | 2012-08-01 |
| A Randomized Controlled Trial to Determine Outcome and Cost Effectiveness of Case Management of Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01512836) | Kronikerenheden Nordjylland | 2012-07-01 |
| Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily (NCT01849341) | Fundación Pública Andaluza Progreso y Salud | 2012-07-01 |
| CorRELation Between PatIent PErception and Findings on Clinical Examination (NCT01627743) | AstraZeneca | 2012-07-01 |
| The Effect of Humidification on Mucus Rheology (NCT01661374) | Virginia Commonwealth University | 2012-07-01 |
| Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01604278) | Novartis Pharmaceuticals | 2012-05-01 |
| Readmissions to Hospital Among Patients With COPD After Telemedicine Video Consultation - a Pilot Project (NCT02006082) | Helse Stavanger HF | 2012-04-01 |
| Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol (NCT01555099) | AstraZeneca | 2012-04-01 |